Delivery Order SPE2DB22D3011-SPE2DB25FP8AH

Award Date 12/12/24
Potential Completion Date 12/13/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP8AH
    Delivery Order

This federal contract award, valued at $1,003.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566698224 units of Montelukast Sodium 10 mg tablets, a medication used to treat conditions such as asthma and allergies.

The contract has an ultimate completion date of December 13, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. As a major supplier of pharmaceutical and medical products to federal agencies, Amerisourcebergen plays a critical role in supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries through its extensive distribution capabilities and contract vehicles.

Generated 3/13/25, 10:11 AM